Kambiz Rahbar (K Rahbar)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 18

Top Venues

European journal of nuclear medicine and molecular imaging

Radiology

Molecular imaging

Cancers

Westfalische Wilhelms Universität Munster

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Westfalische Wilhelms Universität Munster

Germany

Senior Managing Consultant :: Department of Nuclear Medicine, University Hospital Muenster

Publications

Phillip H Kuo, Michael J Morris, Jacob Hesterman, Ayse Tuba Kendi, Kambiz Rahbar, Xiao X Wei, Bruno Fang, Nabil Adra, Rohan Garje, Jeff M Michalski, Kim Chi, Johann S de Bono, Karim Fizazi, Bernd J Krause, A Oliver Sartor, Scott T Tagawa, Samson Ghebremariam, Marcia Brackman, Connie C Wong, Ana M Catafau, Taylor Benson, Andrew J Armstrong, Ken Herrmann
Quantitative 68 Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following 177 Lu-PSMA-617 (VISION Trial). Radiology 312 (2) (2024)
Phillip H Kuo, Michael J Morris, Jacob Hesterman, Ayse Tuba Kendi, Kambiz Rahbar, Xiao X Wei, Bruno Fang, Nabil Adra, Rohan Garje, Jeff M Michalski, Kim Chi, Johann S de Bono, Karim Fizazi, Bernd J Krause, A Oliver Sartor, Scott T Tagawa, Samson Ghebremariam, Marcia Brackman, Connie C Wong, Ana M Catafau, Taylor Benson, Andrew J Armstrong, Ken Herrmann
Quantitative 68 Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following 177 Lu-PSMA-617 (VISION Trial). Radiology 312 (2) (2024)
Phillip H Kuo, Michael J Morris, Jacob Hesterman, Ayse Tuba Kendi, Kambiz Rahbar, Xiao X Wei, Bruno Fang, Nabil Adra, Rohan Garje, Jeff M Michalski, Kim Chi, Johann S de Bono, Karim Fizazi, Bernd J Krause, A Oliver Sartor, Scott T Tagawa, Samson Ghebremariam, Marcia Brackman, Connie C Wong, Ana M Catafau, Taylor Benson, Andrew J Armstrong, Ken Herrmann
Quantitative 68 Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following 177 Lu-PSMA-617 (VISION Trial). Radiology 312 (2) (2024)
Robert Seifert, Sazan Rasul, Konstantin Seitzer, Maria Eveslage, Laya Rahbar Nikoukar, Katharina Kessel, Michael Schäfers, Josef Yu, Alexander R Haug, Marcus Hacker, Martin Boegemann, Lisa Bodei, Michael J Morris, Michael S Hofman, Kambiz Rahbar
A Prognostic Risk Score for Prostate Cancer Based on PSMA PET-derived Organ-specific Tumor Volumes. Radiology (2023)
Elisabeth Relt, Wolfgang Roll, Michael Claesener, Martin Boegemann, Matthias Weckesser, Kambiz Rahbar
Time after Synthesis and Time after Injection Do Not Affect Diagnostic Quality of [ 18 F]F-PSMA 1007 PET. Cancers 14 (20) (2022)
Wolfgang Roll, Matthias Weckesser, Robert Seifert, Lisa Bodei, Kambiz Rahbar
Imaging and liquid biopsy in the prediction and evaluation of response to PRRT in neuroendocrine tumors: implications for patient management. European journal of nuclear medicine and molecular imaging 48 (12) (2021)
Robert Seifert, Katharina Kessel, Katrin Schlack, Manuel Weber, Ken Herrmann, Maximilian Spanke, Wolfgang P Fendler, Boris Hadaschik, Jens Kleesiek, Michael Schäfers, Matthias Weckesser, Martin Boegemann, Kambiz Rahbar
PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis. European journal of nuclear medicine and molecular imaging 48 (4) (2020)
Robert Seifert, Katharina Kessel, Katrin Schlack, Matthias Weckesser, Martin Bögemann, Kambiz Rahbar
Radioligand therapy using [177Lu]Lu-PSMA-617 in mCRPC: a pre-VISION single-center analysis. European journal of nuclear medicine and molecular imaging 47 (9) (2020)
Finn Edler von Eyben, Glenn Bauman, Rie von Eyben, Kambiz Rahbar, Cigdem Soydal, Alexander R Haug, Irene Virgolini, Harshad Kulkarni, Richard Baum, Giovanni Paganelli
Optimizing PSMA Radioligand Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Meta-Analysis. International journal of molecular sciences 21 (23) (2020)
Kambiz Rahbar, Ali Afshar-Oromieh, Martin Bögemann, Stefan Wagner, Michael Schäfers, Lars Stegger, Matthias Weckesser
18F-PSMA-1007 PET/CT at 60 and 120 minutes in patients with prostate cancer: biodistribution, tumour detection and activity kinetics. European journal of nuclear medicine and molecular imaging 45 (8) (2018)
Philipp Backhaus, Benjamin Noto, Nemanja Avramovic, Lena Sophie Grubert, Sebastian Huss, Martin Bögemann, Lars Stegger, Matthias Weckesser, Michael Schäfers, Kambiz Rahbar
Targeting PSMA by radioligands in non-prostate disease-current status and future perspectives. European journal of nuclear medicine and molecular imaging 45 (5) (2018)
Kambiz Rahbar, Ali Afshar-Oromieh, Robert Seifert, Stefan Wagner, Michael Schäfers, Martin Bögemann, Matthias Weckesser
Diagnostic performance of 18F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer. European journal of nuclear medicine and molecular imaging 45 (12) (2018)
Kambiz Rahbar, Matthias Weckesser, Hojjat Ahmadzadehfar, Michael Schäfers, Lars Stegger, Martin Bögemann
Advantage of 18F-PSMA-1007 over 68Ga-PSMA-11 PET imaging for differentiation of local recurrence vs. urinary tracer excretion. European journal of nuclear medicine and molecular imaging 45 (6) (2018)
Kambiz Rahbar, Ali Afshar-Oromieh, Hossein Jadvar, Hojjat Ahmadzadehfar
PSMA Theranostics: Current Status and Future Directions. Molecular imaging 17 (2018)
Kambiz Rahbar, Hojjat Ahmadzadehfar, Martin Boegemann
177Lu-PSMA-617 radioligand therapy in mCRPC: ready for phase III trial? European journal of nuclear medicine and molecular imaging 45 (3) (2017)
Kambiz Rahbar, M Boegemann, A Yordanova, M Eveslage, M Schäfers, M Essler, H Ahmadzadehfar
PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall survival. European journal of nuclear medicine and molecular imaging 45 (1) (2017)
Kambiz Rahbar, Martin Bögeman, Anna Yordanova, Maria Eveslage, Michael Schäfers, Markus Essler, Hojjat Ahmadzadehfar
Delayed response after repeated 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration resistant prostate cancer. European journal of nuclear medicine and molecular imaging 45 (2) (2017)
Kambiz Rahbar, Martin Bögemann, Hojjat Ahmadzadehfar
177Lu-PSMA-617 radioligand therapy of mCRPC: evaluation criteria of response. European journal of nuclear medicine and molecular imaging 44 (1) (2016)

Kambiz Rahbar.css-eqlu8i{font-size:small;padding-left:4px;} (K Rahbar)

Publication Activity (10 Years)

Top Topics

Top Venues

Kambiz Rahbar (K Rahbar)